Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Endocrinology/Neuroendocrine Tumors

Thyroid echogenicity & radioiodine washout rates predicts outcome of radioidine therapy in Graves disease patients

Mohanned Alsuhaibani, Mahmoud. Tuli, Mohei Abouzied, Abdulaziz Al-Sugair, Hamad Aljubair, Mohammed Mohammed and Abdulmohsen Alrashed
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1349;
Mohanned Alsuhaibani
1Radiology, KFSHRC, RDH, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahmoud. Tuli
1Radiology, KFSHRC, RDH, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohei Abouzied
1Radiology, KFSHRC, RDH, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdulaziz Al-Sugair
1Radiology, KFSHRC, RDH, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamad Aljubair
1Radiology, KFSHRC, RDH, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed Mohammed
1Radiology, KFSHRC, RDH, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdulmohsen Alrashed
1Radiology, KFSHRC, RDH, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1349

Objectives To test the hypothesized that the response of the Graves disease (GD) to I-131 can be predicted by the disribution of I-131 within the gland and its retention time.

Methods We retrospectively audited reports of gland size,ultrasound (US) & thyroid uptake of all 534 GD(363 female)mean age 36.5(range 10 to 83)treated in our hospital in 7 years from Oct 2002.Pts were evaluated at 6 months after treatment & categorized as low dose responders (R1)or high dose responders (R2)if they responded to single dose up to 15 mCi or >15 mCi of I-131 respectively & resistant (RS)if they responded to more than single dose. Normal thyroid washout (NW) was defined as 4 hrs uptake < 24 hrs and rapid washout (RW) was defined as 4 hrs uptake equal or higher than 24 hrs uptake.US findings were categorized as normoechogenic(NE), hypoechoic(HO)or hyperechoic(HR).

Results RS glands were larger than responders with average RS,R1 & R2 sizes, 72, 53 and 50 mls respectively. 508 patients(95%) had thyroid uptake evaluated.421(83%)had NW consisted of R1 32%,R2 61%,RS 7% and 87(17%) pts had RW consisted R1(34%),R2(55%),RS(11%).The statistical analysis shows no significant difference.(P value for RS vs R1 is 0.5 & RS vs R2 is 0.253).Out of 111(21%) pts who had US, 66 were(NE),RS(8/12)67%,R1(13/26)50% & R2(45/73)62%,24(HO) patients,RS(2/12)17%,R1(10/26)38%,& R2(12/73)16% and 21(HR)pts RS(2/12)16%, R1(3/26)12% & R2(16/73)22%.Statistical analysis was significant. P value of 0.036.Out of 18 patients who combined (NE)and RW 73% were RS and 27% were both R1+R2.

Conclusions The (NE) thyroid gland have the most colloid content that may bind the I-131. Theoretically the combination of large gland, normoechogenicity with RW gives the least available I-131 for the active follicle cells resulting in maximum resistance to treatment., Hypoechoic and hyperechoic ultrasound features are associated with least colloid content and high radiosensitivity. The distribution of I-131 in the gland is more predictive of the treatment response than the I-131 washout rates alone

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thyroid echogenicity & radioiodine washout rates predicts outcome of radioidine therapy in Graves disease patients
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Thyroid echogenicity & radioiodine washout rates predicts outcome of radioidine therapy in Graves disease patients
Mohanned Alsuhaibani, Mahmoud. Tuli, Mohei Abouzied, Abdulaziz Al-Sugair, Hamad Aljubair, Mohammed Mohammed, Abdulmohsen Alrashed
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1349;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Thyroid echogenicity & radioiodine washout rates predicts outcome of radioidine therapy in Graves disease patients
Mohanned Alsuhaibani, Mahmoud. Tuli, Mohei Abouzied, Abdulaziz Al-Sugair, Hamad Aljubair, Mohammed Mohammed, Abdulmohsen Alrashed
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1349;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Endocrinology/Neuroendocrine Tumors

  • Role of 123-Iodine MIBG SPECT/CT in patients with clinically suspected or histological confirmed neuroendocrine tumours
  • Role of 111-Indium Octreotide SPECT/CT in suspected recurrent medullary thyroid cancer
  • The 2-hour delayed SUV and retention index calculated with dual-phase F-18 FDG PET distinguishes between benign and malignant thyroid carcinoma
Show more General Clinical Specialties: Endocrinology/Neuroendocrine Tumors

Endocrinology/Neuroendocrine Tumors Posters

  • Added value of 111-Indium octreotide SPECT/CT in the imaging of neuroendocrine tumours
  • The 2-hour delayed SUV and retention index calculated with dual-phase F-18 FDG PET distinguishes between benign and malignant thyroid carcinoma
  • Usefulness of PET/CT investigations with 68Ga-DOTATATE in neuroendocrine tumors in diagnosis of primary tumors
Show more Endocrinology/Neuroendocrine Tumors Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire